Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Chemico-Biological Interactions|March 18, 2026
Astrocyte-microglia crosstalk in Lead-induced neurotoxicity: Molecular signaling and downstream pathological sequelaeSuman Maity, Moumita Saha, Zahwa Fathima, et al.
International Journal of Pharmaceutics|September 12, 2024
Breaking barriers in cancer management: The promising role of microsphere conjugates in cancer diagnosis and therapyAshutosh Gupta, Sanjay Kulkarni, Soji Soman, et al.
Heliyon|October 9, 2023
Treatment of H. pylori infection and gastric ulcer: Need for novel Pharmaceutical formulationAshutosh Gupta, Shiran Shetty, Srinivas Mutalik, et al.
Environmental Geochemistry and Health|August 4, 2019
Health risk assessment of heavy metal accumulation in the Buriganga and Turag River systems for Puntius ticto, Heteropneustes fossilis, and Channa punctatusMohammad Abdul Baki, Md Fajlul Haque Shojib, Subrina Sehrin, et al.
ACS Omega|July 21, 2025
Targeting Urease: A Promising Adjuvant Strategy for Effective EradicationShivani Kunkalienkar, Neha S Gandhi, Ashutosh Gupta, et al.
Molecular Pharmaceutics|November 14, 2025
Design and Characterization of Novel Gastroretentive Drug Delivery System of Antibiotics and Piperine for the Eradication of H. pylori InfectionAshutosh Gupta, Moumita Saha, Shivani Shailesh Kunkalienkar, et al.
F1000Research|July 18, 2020
Phytochemical composition analysis and evaluation of in vitro medicinal properties and cytotoxicity of five wild weeds: A comparative studyPranabesh Ghosh, Chandrima Das, Swagata Biswas, et al.
Cell Reports|April 10, 2025
Dietary oleic acid drives obesogenic adipogenesis via modulation of LXRα signalingAllison Wing, Elise Jeffery, Christopher D Church, et al.
Cancers|January 11, 2022
CANDIED: A Pan-Canadian Cohort of Immune Checkpoint Inhibitor-Induced Insulin-Dependent Diabetes MellitusThiago P Muniz, Daniel V Araujo, Kerry J Savage, et al.
Nature Communications|January 20, 2022
A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19Yogiraj Ray, Shekhar Ranjan Paul, Purbita Bandopadhyay, et al.
Pageof 5